Creo Medical (LSE: CREO)
GBX 35.98
(0.0%)
GBX 0.00
Price as of May 2, 2024, 4:08 a.m. ET
Creo Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Creo Medical Company Info
Creo Medical Group Plc operates as a medical device company that focuses on surgical endoscopy. It develops CROMA, an electrosurgical platform that delivers microwave and bipolar radio frequency for precise localized cutting and microwave for controlled coagulation. The company was founded by Mohammed Sabih Chaudhry on September 12, 2016 and is headquartered in Chepstow, the United Kingdom.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.